These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1595 related items for PubMed ID: 18364011

  • 1. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
    Gray A, Raff AB, Chiriva-Internati M, Chen SY, Kast WM.
    Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
    [Abstract] [Full Text] [Related]

  • 2. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
    Hwang C, Sanda MG.
    Curr Opin Mol Ther; 1999 Aug; 1(4):471-9. PubMed ID: 11713762
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic cancer vaccines.
    Acres B, Paul S, Haegel-Kronenberger H, Calmels B, Squiban P.
    Curr Opin Mol Ther; 2004 Feb; 6(1):40-7. PubMed ID: 15011780
    [Abstract] [Full Text] [Related]

  • 4. Immunizing against breast cancer: a new swing for an old sword.
    Curigliano G, Locatelli M, Fumagalli L, Goldhirsch A.
    Breast; 2009 Oct; 18 Suppl 3():S51-4. PubMed ID: 19914543
    [Abstract] [Full Text] [Related]

  • 5. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B, Siegel SE, Kaiser HE.
    Anticancer Res; 1996 Oct; 16(2):661-74. PubMed ID: 8687112
    [Abstract] [Full Text] [Related]

  • 6. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
    Shu S, Cochran AJ, Huang RR, Morton DL, Maecker HT.
    Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
    [Abstract] [Full Text] [Related]

  • 7. Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials.
    Mosolits S, Nilsson B, Mellstedt H.
    Expert Rev Vaccines; 2005 Jun; 4(3):329-50. PubMed ID: 16026248
    [Abstract] [Full Text] [Related]

  • 8. Cancer vaccines. Any future?
    Myc LA, Gamian A, Myc A.
    Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):249-59. PubMed ID: 21644030
    [Abstract] [Full Text] [Related]

  • 9. Active vaccination after allogeneic bone marrow cell transplantation: a new option in the immunotherapy of cancer?
    Zöller M, Matzku S.
    Arch Immunol Ther Exp (Warsz); 2002 Aug; 50(3):197-224. PubMed ID: 12098935
    [Abstract] [Full Text] [Related]

  • 10. Recent developments in therapeutic cancer vaccines.
    Morse MA, Chui S, Hobeika A, Lyerly HK, Clay T.
    Nat Clin Pract Oncol; 2005 Feb; 2(2):108-13. PubMed ID: 16264883
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic human papillomavirus vaccination.
    Albers AE, Kaufmann AM.
    Public Health Genomics; 2009 Feb; 12(5-6):331-42. PubMed ID: 19684445
    [Abstract] [Full Text] [Related]

  • 12. Advances in dendritic-cell-based therapeutic vaccines for cervical cancer.
    Bellone S, Pecorelli S, Cannon MJ, Santin AD.
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1473-86. PubMed ID: 17944571
    [Abstract] [Full Text] [Related]

  • 13. [Oncoimmunology: some fundamental problems of cancer immunotherapy].
    Nedospasov SA, Kuprash DV.
    Mol Biol (Mosk); 2007 Oct; 41(2):355-68. PubMed ID: 17514902
    [Abstract] [Full Text] [Related]

  • 14. Dendritic cells in cancer immunotherapy.
    Vulink A, Radford KJ, Melief C, Hart DN.
    Adv Cancer Res; 2008 Oct; 99():363-407. PubMed ID: 18037410
    [Abstract] [Full Text] [Related]

  • 15. A clinical development paradigm for cancer vaccines and related biologics.
    Hoos A, Parmiani G, Hege K, Sznol M, Loibner H, Eggermont A, Urba W, Blumenstein B, Sacks N, Keilholz U, Nichol G, Cancer Vaccine Clinical Trial Working Group.
    J Immunother; 2007 Jan; 30(1):1-15. PubMed ID: 17198079
    [Abstract] [Full Text] [Related]

  • 16. Development of vaccines against self-antigens: the p53 paradigm.
    Chada S, Mhashilkar A, Roth JA, Gabrilovich D.
    Curr Opin Drug Discov Devel; 2003 Mar; 6(2):169-73. PubMed ID: 12669451
    [Abstract] [Full Text] [Related]

  • 17. The use of dendritic cells in cancer immunotherapy.
    Nencioni A, Grünebach F, Schmidt SM, Müller MR, Boy D, Patrone F, Ballestrero A, Brossart P.
    Crit Rev Oncol Hematol; 2008 Mar; 65(3):191-9. PubMed ID: 18055210
    [Abstract] [Full Text] [Related]

  • 18. A new era in anticancer peptide vaccines.
    Perez SA, von Hofe E, Kallinteris NL, Gritzapis AD, Peoples GE, Papamichail M, Baxevanis CN.
    Cancer; 2010 May 01; 116(9):2071-80. PubMed ID: 20187092
    [Abstract] [Full Text] [Related]

  • 19. Reversal of tumor-mediated immunosuppression.
    Vieweg J, Su Z, Dahm P, Kusmartsev S.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 2):727s-732s. PubMed ID: 17255301
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic cancer vaccines.
    Morris LF, Ribas A.
    Surg Oncol Clin N Am; 2007 Oct 15; 16(4):819-31, ix. PubMed ID: 18022546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 80.